Prophylactic uses of antiarrhythmic drugs in acute myocardial infarction.
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000145:classification / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D001285:Atropine / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D007545:Isoproterenol / Q000627:therapeutic use; D008012:Lidocaine / Q000008:administration & dosage / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy*; D010672:Phenytoin / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D013997:Time Factors; D014693:Ventricular Fibrillation / Q000209:etiology / Q000401:mortality
D000889:Anti-Arrhythmia Agents; D010672:Phenytoin; D001285:Atropine; D008012:Lidocaine; D011433:Propranolol; D011802:Quinidine; D011342:Procainamide; D007545:Isoproterenol